TDB Funds Clearsynth for Deuterated Chemical Facility
In a major leap for India’s chemical innovation, the Technology Development Board (TDB) has extended financial support to Clearsynth Labs Limited. This funding will help set up a dedicated bulk manufacturing facility for deuterated reagents and building blocks—a vital component in advanced research and high-tech applications.
Deuterium-based compounds are gaining momentum worldwide. Not only are they essential in pharmaceutical research, but they are also critical in OLED technology, semiconductors, and fiber optics.
Although India has a strong pharmaceutical sector, it still imports most of its deuterated solvents. Consequently, the country remains dependent on foreign suppliers for high-purity, isotope-labelled materials. This project aims to change that.
Bridging the Import Gap
With TDB’s support, Clearsynth will establish an indigenous production facility. This plant is expected to:
-
Reduce India’s import dependency
-
Improve access to specialty chemicals
-
Create export opportunities for local manufacturers
More importantly, it aligns with the goals of Atmanirbhar Bharat and Make in India by fostering innovation and self-reliance.
A Strategic Tie-Up for Sustainability
Furthermore, Clearsynth has entered into a long-term agreement with the Heavy Water Board (HWB) under the Department of Atomic Energy. This ensures a consistent supply of high-quality heavy water—essential for manufacturing deuterated reagents at scale.
As a result, the facility gains a significant competitive edge in terms of both cost and capacity.
Key Advantages of the Project
Thanks to this initiative, India can finally position itself as a global supplier in a high-value niche market. The project offers multiple benefits:
-
Encourages domestic innovation and IP creation
-
Saves valuable foreign exchange
-
Generates high-skilled jobs in R&D and manufacturing
-
Meets rising global demand in a timely and cost-effective manner
Moreover, this project sets the tone for future investments in advanced specialty chemicals.
Voices of Leadership
Shri Rajesh Kumar Pathak, Secretary of TDB, remarked:
“This initiative enables India to capitalize on the rapidly expanding market for deuterated compounds. TDB’s support is crucial in building a world-class facility.”
Meanwhile, Mr. Vijay Ambati, MD & CEO of Clearsynth, shared:
“Creating deuterated solvents that meet global standards is complex and costly. However, with TDB’s assistance, we are confident in our ability to build a competitive, scalable model.”
Unlocking India’s Potential in High-Tech Chemistry
With global demand rising fast, India has a timely opportunity to lead in high-purity, isotope-labelled compounds. The Clearsynth facility is more than just a manufacturing unit—it represents a shift in how India approaches strategic technologies and chemical sovereignty.
Going forward, this initiative will encourage more private players to invest in cutting-edge sectors that were previously import-heavy. It also sets a new benchmark for public-private partnerships in science and technology.